SLCO1B7 and lung carcinoma: The results demonstrated that loss of AR promoted lung cancer metastasis, however, when shcirc-SLCO1B7 was introduced in combination with shAR, it effectively blocked shAR-mediated lung cancer metastasis (Fig. 7A).